Study of Sargramostim in Moderately to Severely Active Crohn's Disease

NCT00329537 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Sargramostim (Leukine)
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company